Medindia LOGIN REGISTER
Medindia
Advertisement

Autism's Behavioral Symptoms may be Reversed by Under Trial Cancer Drug

by Kathy Jones on November 30, 2014 at 9:49 PM
 Autism's Behavioral Symptoms may be Reversed by Under Trial Cancer Drug

A drug undergoing test as a treatment for cancer could also help reverse autism's behavioral symptoms, says a new study.

Researchers from the University of Edinburgh and McGill University have identified a chemical pathway that goes awry in the brains of Fragile X patients, stated that a cancer drug candidate could reverse their behavioral symptoms and found that a naturally occurring anti-fungal called cercosporamide can block the pathway and improve sociability in mice with the condition.

Advertisement

The team identified a key molecule - eIF4E - that drives excess protein production in the brains of Fragile X patients. This can cause behavioural symptoms that include learning difficulties. It can also lead to more serious intellectual disabilities, delays in speech and language development and problems with social interactions.

The team found that treatment with cercosporamide blocks the activity of eIF4E, and therefore reduces the amounts of MMP-9, and reverses the behavioural symptoms in mice with a version of Fragile X Syndrome. The new findings suggested that it could have a use as a treatment for patients with Fragile X Syndrome.
Advertisement

Christos Gkogkas, of the University of Edinburgh's Patrick Wild Centre for Research into Autism, Fragile X Syndrome and Intellectual Disabilities, said that by designing treatments that block just this pathway, it is hoped that they can limit the potential side-effects and develop therapies that are more efficient than general treatment approaches.

The study is published in the journal Cell Reports.

Source: ANI
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Autism's Behavioral Symptoms may be Reversed by Under Trial Cancer Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests